{"id":49727,"date":"2022-10-18T08:02:27","date_gmt":"2022-10-18T06:02:27","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/cmp-scientific-signs-a-co-marketing-agreement-with-agilent-to-advance-capillary-electrophoresis-mass-spectrometry-solutions\/"},"modified":"2022-10-18T08:02:27","modified_gmt":"2022-10-18T06:02:27","slug":"cmp-scientific-signs-a-co-marketing-agreement-with-agilent-to-advance-capillary-electrophoresis-mass-spectrometry-solutions","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/cmp-scientific-signs-a-co-marketing-agreement-with-agilent-to-advance-capillary-electrophoresis-mass-spectrometry-solutions\/","title":{"rendered":"CMP Scientific Signs a Co-Marketing Agreement with Agilent to Advance Capillary Electrophoresis\u2013Mass Spectrometry Solutions"},"content":{"rendered":"
\n

BROOKLYN, N.Y.–(BUSINESS WIRE)–#BioSpace<\/a>–CMP Scientific Corp., a leader in Capillary Electrophoresis-Mass Spectrometry (CE-MS) technologies, today announced that it has signed a global co-marketing agreement with Agilent Technologies to provide an integrated CE-MS solution to life science and pharmaceutical industry.\n<\/p>\n

<\/a><\/p>\n

\nCMP Scientific develops, manufactures, and sells products and analytical instruments in life sciences, diagnostics, and applied markets. CMP and Agilent will work together to implement new applications for the CE-MS system, which is a sensitive, alternative method to liquid chromatography-mass spectrometry (LC-MS) in mapping biological components. One of CMP\u2019s major products, EMASS-II CE-MS ion source integrates seamlessly with the Agilent\u2019s MS instruments to identify therapeutic monoclonal antibody (mAb) charge variants, and to analyze other diverse biological molecules.\n<\/p>\n

\nCMP first introduced the EMASS-II CE-MS, which utilizes an electrokinetically pumped nanospray sheath liquid interface to provide reliable and robust performance, in 2015. Leading biopharmaceutical companies now routinely use the EMASS-II CE-MS ion source in high sensitivity applications ranging from mAb intact mass analysis, charge variant analysis, CE-SDS impurity analysis, subunit analysis, peptide mapping analysis, biosimilar comparisons to preclinical biotransformation studies. This interface has also been globally employed for metabolite analysis, nucleic acid analysis and polysaccharide analysis.\n<\/p>\n

\nStrategic collaborations between CMP and Agilent in last five years have generated great values to both companies. There were countless inspirational stories in the pre-clinical biotransformation studies on the platform. CMP leveraged on this strategic collaboration and established innovative centers in New York and Shanghai, which managed to initiate hundreds of active projects for pharmaceuticals.\n<\/p>\n

\nThe renewal of partnership between CMP and Agilent will enable both to align applications, providing biopharma with a larger range of capabilities to enhance the development of biotherapeutics, and achieve breakthroughs in proteomics and metabolomics.\n<\/p>\n

\nFor CMP\u2019s complete product line, please visit www.cmpscientific.com\/products-and-services<\/a>\n<\/p>\n

\nAbout CMP Scientific Corp: <\/b>Founded in 2009, <\/b>CMP is a global analytical instrument company with advanced, proprietary CE-MS technologies. CMP develops and markets EMAST-A CE-ESI-TOF, EMASS-II CE-MS ion source, ECE-001 CE system, consumables and method development services to solve challenging analytical problems. Our customers are biotechnology, pharmaceuticals, and research institutions. With a focus on quality and customer services, our innovative products advance life science and clinical treatment to make the world safer, healthier, better. For more information, please visit www.cmpscientific.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nDr. James Xia<\/b>
CMP Scientific Corp<\/b>
+1 718-360-7803<\/b>
james.xia@cmpscientific.com<\/a><\/b>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

BROOKLYN, N.Y.–(BUSINESS WIRE)–#BioSpace–CMP Scientific Corp., a leader in Capillary Electrophoresis-Mass Spectrometry (CE-MS) technologies, today announced that it has signed a global co-marketing agreement with Agilent Technologies to provide an integrated CE-MS solution to life science and pharmaceutical industry. CMP Scientific develops, manufactures, and sells products and analytical instruments in life sciences, diagnostics, and applied markets. … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49727","6":"format-standard","7":"category-industry"},"yoast_head":"\nCMP Scientific Signs a Co-Marketing Agreement with Agilent to Advance Capillary Electrophoresis\u2013Mass Spectrometry Solutions - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/cmp-scientific-signs-a-co-marketing-agreement-with-agilent-to-advance-capillary-electrophoresis-mass-spectrometry-solutions\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CMP Scientific Signs a Co-Marketing Agreement with Agilent to Advance Capillary Electrophoresis\u2013Mass Spectrometry Solutions - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"BROOKLYN, N.Y.–(BUSINESS WIRE)–#BioSpace–CMP Scientific Corp., a leader in Capillary Electrophoresis-Mass Spectrometry (CE-MS) technologies, today announced that it has signed a global co-marketing agreement with Agilent Technologies to provide an integrated CE-MS solution to life science and pharmaceutical industry. CMP Scientific develops, manufactures, and sells products and analytical instruments in life sciences, diagnostics, and applied markets. ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/cmp-scientific-signs-a-co-marketing-agreement-with-agilent-to-advance-capillary-electrophoresis-mass-spectrometry-solutions\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-18T06:02:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221017006021\/en\/1604922\/21\/CMP_Logo_24Jan2021.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cmp-scientific-signs-a-co-marketing-agreement-with-agilent-to-advance-capillary-electrophoresis-mass-spectrometry-solutions\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cmp-scientific-signs-a-co-marketing-agreement-with-agilent-to-advance-capillary-electrophoresis-mass-spectrometry-solutions\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"CMP Scientific Signs a Co-Marketing Agreement with Agilent to Advance Capillary Electrophoresis\u2013Mass Spectrometry Solutions\",\"datePublished\":\"2022-10-18T06:02:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cmp-scientific-signs-a-co-marketing-agreement-with-agilent-to-advance-capillary-electrophoresis-mass-spectrometry-solutions\\\/\"},\"wordCount\":409,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cmp-scientific-signs-a-co-marketing-agreement-with-agilent-to-advance-capillary-electrophoresis-mass-spectrometry-solutions\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221017006021\\\/en\\\/1604922\\\/21\\\/CMP_Logo_24Jan2021.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cmp-scientific-signs-a-co-marketing-agreement-with-agilent-to-advance-capillary-electrophoresis-mass-spectrometry-solutions\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cmp-scientific-signs-a-co-marketing-agreement-with-agilent-to-advance-capillary-electrophoresis-mass-spectrometry-solutions\\\/\",\"name\":\"CMP Scientific Signs a Co-Marketing Agreement with Agilent to Advance Capillary Electrophoresis\u2013Mass Spectrometry Solutions - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cmp-scientific-signs-a-co-marketing-agreement-with-agilent-to-advance-capillary-electrophoresis-mass-spectrometry-solutions\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cmp-scientific-signs-a-co-marketing-agreement-with-agilent-to-advance-capillary-electrophoresis-mass-spectrometry-solutions\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221017006021\\\/en\\\/1604922\\\/21\\\/CMP_Logo_24Jan2021.jpg\",\"datePublished\":\"2022-10-18T06:02:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cmp-scientific-signs-a-co-marketing-agreement-with-agilent-to-advance-capillary-electrophoresis-mass-spectrometry-solutions\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cmp-scientific-signs-a-co-marketing-agreement-with-agilent-to-advance-capillary-electrophoresis-mass-spectrometry-solutions\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cmp-scientific-signs-a-co-marketing-agreement-with-agilent-to-advance-capillary-electrophoresis-mass-spectrometry-solutions\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221017006021\\\/en\\\/1604922\\\/21\\\/CMP_Logo_24Jan2021.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221017006021\\\/en\\\/1604922\\\/21\\\/CMP_Logo_24Jan2021.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cmp-scientific-signs-a-co-marketing-agreement-with-agilent-to-advance-capillary-electrophoresis-mass-spectrometry-solutions\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CMP Scientific Signs a Co-Marketing Agreement with Agilent to Advance Capillary Electrophoresis\u2013Mass Spectrometry Solutions\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CMP Scientific Signs a Co-Marketing Agreement with Agilent to Advance Capillary Electrophoresis\u2013Mass Spectrometry Solutions - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/cmp-scientific-signs-a-co-marketing-agreement-with-agilent-to-advance-capillary-electrophoresis-mass-spectrometry-solutions\/","og_locale":"en_US","og_type":"article","og_title":"CMP Scientific Signs a Co-Marketing Agreement with Agilent to Advance Capillary Electrophoresis\u2013Mass Spectrometry Solutions - Pharma Trend","og_description":"BROOKLYN, N.Y.–(BUSINESS WIRE)–#BioSpace–CMP Scientific Corp., a leader in Capillary Electrophoresis-Mass Spectrometry (CE-MS) technologies, today announced that it has signed a global co-marketing agreement with Agilent Technologies to provide an integrated CE-MS solution to life science and pharmaceutical industry. CMP Scientific develops, manufactures, and sells products and analytical instruments in life sciences, diagnostics, and applied markets. ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/cmp-scientific-signs-a-co-marketing-agreement-with-agilent-to-advance-capillary-electrophoresis-mass-spectrometry-solutions\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-18T06:02:27+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221017006021\/en\/1604922\/21\/CMP_Logo_24Jan2021.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/cmp-scientific-signs-a-co-marketing-agreement-with-agilent-to-advance-capillary-electrophoresis-mass-spectrometry-solutions\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/cmp-scientific-signs-a-co-marketing-agreement-with-agilent-to-advance-capillary-electrophoresis-mass-spectrometry-solutions\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"CMP Scientific Signs a Co-Marketing Agreement with Agilent to Advance Capillary Electrophoresis\u2013Mass Spectrometry Solutions","datePublished":"2022-10-18T06:02:27+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/cmp-scientific-signs-a-co-marketing-agreement-with-agilent-to-advance-capillary-electrophoresis-mass-spectrometry-solutions\/"},"wordCount":409,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/cmp-scientific-signs-a-co-marketing-agreement-with-agilent-to-advance-capillary-electrophoresis-mass-spectrometry-solutions\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221017006021\/en\/1604922\/21\/CMP_Logo_24Jan2021.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/cmp-scientific-signs-a-co-marketing-agreement-with-agilent-to-advance-capillary-electrophoresis-mass-spectrometry-solutions\/","url":"https:\/\/pharma-trend.com\/en\/cmp-scientific-signs-a-co-marketing-agreement-with-agilent-to-advance-capillary-electrophoresis-mass-spectrometry-solutions\/","name":"CMP Scientific Signs a Co-Marketing Agreement with Agilent to Advance Capillary Electrophoresis\u2013Mass Spectrometry Solutions - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/cmp-scientific-signs-a-co-marketing-agreement-with-agilent-to-advance-capillary-electrophoresis-mass-spectrometry-solutions\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/cmp-scientific-signs-a-co-marketing-agreement-with-agilent-to-advance-capillary-electrophoresis-mass-spectrometry-solutions\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221017006021\/en\/1604922\/21\/CMP_Logo_24Jan2021.jpg","datePublished":"2022-10-18T06:02:27+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/cmp-scientific-signs-a-co-marketing-agreement-with-agilent-to-advance-capillary-electrophoresis-mass-spectrometry-solutions\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/cmp-scientific-signs-a-co-marketing-agreement-with-agilent-to-advance-capillary-electrophoresis-mass-spectrometry-solutions\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/cmp-scientific-signs-a-co-marketing-agreement-with-agilent-to-advance-capillary-electrophoresis-mass-spectrometry-solutions\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221017006021\/en\/1604922\/21\/CMP_Logo_24Jan2021.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221017006021\/en\/1604922\/21\/CMP_Logo_24Jan2021.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/cmp-scientific-signs-a-co-marketing-agreement-with-agilent-to-advance-capillary-electrophoresis-mass-spectrometry-solutions\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"CMP Scientific Signs a Co-Marketing Agreement with Agilent to Advance Capillary Electrophoresis\u2013Mass Spectrometry Solutions"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49727","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49727"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49727\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49727"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49727"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49727"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}